Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic and Wegovy, works by slowing stomach emptying and activating brain satiety centers—effects that typically require consistent use to build and maintain. Many people ask whether one month of treatment can produce meaningful results, but clinical evidence shows that sustainable weight loss with GLP-1 therapy depends on continuation and dose escalation over time.

How Semaglutide Works in Your Body

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your gut produces when you eat. Once you take a dose, the medication circulates through your bloodstream and binds to GLP-1 receptors in your brain, pancreas, and digestive tract. This binding triggers signals that reduce hunger, increase feelings of fullness, and slow the rate at which food moves from your stomach into your intestines.

The therapeutic effects of semaglutide build gradually over weeks and months. Your initial dose is typically much lower than your maintenance dose because this escalation approach helps your body adjust and reduces side effects. After 4 weeks, most people move to a higher dose; after 8 weeks, another increase occurs. This dose-escalation pattern is why one month alone rarely delivers maximum benefit—your body is still in the adaptation phase.

One Month of Semaglutide: What the Evidence Shows

Clinical trials of semaglutide for weight loss, including the STEP trials, measured outcomes over 68 weeks or longer. Participants who stayed on treatment lost significantly more weight than those who stopped early or used the medication briefly. In the first month alone, most people experience modest weight loss (typically 2–5 pounds) plus reduced appetite and improved meal satisfaction.

After stopping semaglutide, even short-term users often regain weight quickly because the appetite-suppressing effects fade within days. Your hunger signals return to baseline, and without the medication's support, many people revert to previous eating patterns. For sustained, meaningful weight loss, clinical guidelines recommend continuing semaglutide for at least 3–6 months, with many people benefiting from longer-term use.

Why Short-Term Semaglutide Use May Not Deliver Long-Term Results

Using semaglutide for only one month is analogous to starting a fitness program and quitting after a week—you won't see the transformation your body is capable of achieving. During the first 30 days, your dose is at the starting level (0.25 mg weekly), which is designed to let your system tolerate the medication rather than produce maximum weight loss. The real metabolic impact emerges once you reach therapeutic doses over subsequent months.

Additionally, sustained weight loss requires behavioral change: new eating habits, mindful food choices, and activity increases all work alongside semaglutide. One month is rarely enough time to solidify these changes or to understand how the medication affects your individual hunger patterns and energy levels. Most patients who benefit most from semaglutide commit to at least 6 months of continuous therapy, allowing time for dose optimization and habit formation.

PlexusDx Compounded Semaglutide: Flexible Monthly Access Without Commitment Pressure

PlexusDx offers compounded semaglutide injections starting at $149 per month, manufactured by licensed 503A compounding pharmacies and available to patients in all 50 states without insurance requirements. Unlike some weight-loss programs that lock patients into multi-month contracts, PlexusDx structures pricing as a simple flat monthly rate—your dose may need to go up as your body adapts, but your price won't change based on dosing level.

For patients who want to explore semaglutide briefly, PlexusDx monthly flexibility means you can start without long-term financial commitment. However, our clinical team recommends discussing your goals honestly: if you're interested in meaningful, sustained weight loss, planning for 6 months or more maximizes the medication's effectiveness and lets your body and mind adapt to new eating patterns. PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after your first month), which maps 49 peptides and 150+ genetic insights across 14 metabolic pathways to help personalize your weight-loss strategy.

The Role of Genetic Factors in Your Semaglutide Response

Not everyone responds to semaglutide identically. Your genetic makeup influences how effectively your body processes the medication and how much appetite suppression you experience. Specific genetic variants—such as those in the GLP1R and GIPR genes—can affect the strength of your response and the dose level that works best for you. Understanding these predispositions helps explain why some people need longer dose-escalation timelines or why their appetite reduction patterns differ from others'.

PlexusDx's Precision Peptide Genetic Test examines key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 to reveal how your body's peptide pathways influence weight, hunger signaling, and metabolic rate. This genetic insight, combined with consistent semaglutide use over 3–6 months, allows PlexusDx clinicians to tailor dosing and help you achieve personalized results rather than relying on a one-size-fits-all approach.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I lose weight in just one month on semaglutide?

Yes, you may see initial weight loss (2–5 pounds) in your first month, along with reduced hunger and better meal satisfaction. However, one month is only the beginning phase of therapy, and most weight loss occurs after 3–6 months of consistent use at therapeutic doses. PlexusDx recommends viewing your first month as the start of a longer-term commitment for best results.

What happens to my weight after I stop semaglutide for one month?

Clinical evidence shows that weight often returns within weeks to months after stopping semaglutide, since the appetite-suppressing effects fade as the medication leaves your system. People typically regain most or all of the weight lost if they revert to previous eating patterns without ongoing behavioral support.

How much does PlexusDx compounded semaglutide cost if I want to try it for one month?

PlexusDx compounded semaglutide injections start at $149 per month, with no long-term contract required and no membership fees. Your dose may increase over time as you progress through the escalation schedule, but your monthly price remains flat—it won't go up based on dosing level.

Is compounded semaglutide as effective as brand-name Ozempic or Wegovy?

PlexusDx compounded semaglutide is manufactured by licensed 503A compounding pharmacies using the same active ingredient and meets stringent quality standards. While compounded medications are not FDA-approved as finished products, they are made under strict pharmacy regulations and have been prescribed safely for decades. Efficacy depends on consistent use, proper dosing, and individual factors like genetics and lifestyle.

How can the PlexusDx Precision Peptide Genetic Test help me decide on semaglutide?

The Precision Peptide Genetic Test ($99 add-on after your first month) examines 49 peptides and 150+ genetic insights across 14 pathways, including GLP1R and GIPR variants that directly influence your semaglutide response. This personalized data helps your PlexusDx clinician predict how well semaglutide will work for you and whether you might benefit from a longer commitment or a different compound like tirzepatide.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves